Insider to sell 20,000 shares via Oppenheimer

A holder of ordinary shares of DRTS has filed a notice of proposed sale under Rule 144.

Accepted by SEC EDGAR 01/09/2026 - 06:06 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of ordinary shares of DRTS has filed a notice of proposed sale under Rule 144. The filing states an intention to sell 20,000 ordinary shares through Oppenheimer & Co. Inc. on the Nasdaq market, with an aggregate market value of $118,000. These shares are part of 70,000 restricted stock units (RSUs) that were acquired from the issuer on 08/08/2021. The notice also reports that there were 70,380,570 shares of this class outstanding, providing a sense of the company’s total equity base.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DRTS Form 144 filing disclose?

The Form 144 discloses that a holder of DRTS ordinary shares plans to sell 20,000 shares on Nasdaq through Oppenheimer & Co. Inc. with an aggregate market value of $118,000.

How many DRTS shares are planned to be sold under this Form 144?

The notice indicates an intended sale of 20,000 ordinary shares of DRTS.

What is the approximate market value of the DRTS shares to be sold?

The Form 144 lists an aggregate market value of $118,000 for the 20,000 ordinary shares proposed to be sold.

When were the DRTS shares to be sold originally acquired?

The securities to be sold come from RSUs that were acquired from the issuer on 08/08/2021, in an amount of 70,000 securities.

Which broker is handling the planned DRTS share sale?

The filing identifies Oppenheimer & Co. Inc., located at Broad 85 St., New York, NY 10004, as the broker for the proposed sale on Nasdaq.

How many DRTS shares of this class were outstanding?

For context, the Form 144 reports 70,380,570 ordinary shares of this class as outstanding.

When is the approximate date of the planned DRTS share sale?

The filing lists an approximate date of sale of 01/08/2026 for the proposed transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Levy Raphi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. Broad 85 St. New York NY 10004	20000	118000.00	70380570	01/08/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/08/2021	RSU	Issuer			70000	08/08/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under 10b5 sale plan signed on 03-17-25
Date of Notice	01/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Levy Raphi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)